Browsing Tag
Dementia
11 posts
FIFA World Cup 2026 sensory rooms: How stadium accessibility is becoming a fan safety issue
World Cup access is changing. FIFA 2026 sensory rooms show how fan safety now includes autism, anxiety and invisible disability support.
Alzheimer’s blood test breakthrough raises hopes for earlier dementia risk detection
Alzheimer’s may start long before memory loss. Blood tests could shift dementia care from late diagnosis to earlier risk planning.
Can high blood pressure accelerate memory loss and increase long-term risks to brain health?
High blood pressure can damage brain vessels, reduce oxygen supply, and accelerate memory loss. Learn how early control protects cognitive health.
Corium, Lotus Pharmaceutical seal deal for Alzheimer’s drug ADLARITY in Asia
Corium, a biopharmaceutical frontrunner in the neuroscience arena, and Lotus Pharmaceutical, a global pharmaceutical powerhouse, have declared a…
Suven Life Sciences begins Masupirdine phase 3 clinical trial in dementia patients
Suven Life Sciences has started a global phase 3 clinical trial of Masupirdine in dementia of the Alzheimer’s…
MGC Pharmaceuticals signs supply deal with AMC for phytomedicine products
MGC Pharmaceuticals, a developer of phytocannabinoid-derived medicines, has signed a $24 million supply and distribution deal with US-based…
Suven Life Sciences to launch phase 3 clinical trial for Masupirdine
Suven Life Sciences is set to launch a phase 3 clinical trial for its 5-HT6 antagonist SUVN-502 (Masupirdine)…
Eli Lilly completes $1.04bn acquisition of Prevail Therapeutics to expand gene therapy program
Eli Lilly and Company has officially finalized its acquisition of Prevail Therapeutics in a deal valued at up…
PostEra collaborates with NeuroLucent to accelerate Alzheimer’s drug discovery
In a strategic move aimed at fast-tracking the development of new treatments for Alzheimer’s disease, PostEra, a UK-based…
PostEra partners with NeuroLucent to accelerate Alzheimer’s drug development using AI and machine learning
In a significant move within the biotech industry, PostEra, a UK-based biotechnology company, has entered into a strategic…